Archive — US — techcrunch
Startup Battlefield company SpotitEarly trained dogs and AI to sniff out commoncancers and will show off its tech at Disrupt
SpotitEarly, a biotech startup, has developed an innovative at-home cancer screening test that uses the combined abilities of trained dogs and AI to detect cancer through human breath samples. The company, which will showcase its technology at TechCrunch Disrupt 2025, aims to make early cancer detection more accessible and affordable, with plans for a launch in the U.S. market next year.
Key points
- SpotitEarly has trained beagles to detect cancer-specific odors in breath samples.
- The company's AI validates the dogs' responses, achieving a 94% accuracy in cancer detection.
- SpotitEarly plans to sell at-home screening kits through a physician network for around $250.
- The startup received $20.3 million in funding to expand clinical studies, beginning with breast cancer detection.
- Its multi-cancer panel will be priced below competitors, aiming to become accessible for more consumers.
Why it matters
- The rise of AI in healthcare reflects a wider trend toward personalized medicine and early detection.
- SpotitEarly is part of a growing focus on innovative cancer detection methods, competing with other companies like Grail and Prenuvo.
- The integration of animals in medical diagnostics taps into the longstanding human-animal bond, leveraging capabilities often overlooked in technology.
SpotitEarly's approach signifies a revolutionary step in cancer screening, blending canine intuition with advanced technology, potentially reshaping future healthcare practices and improving early detection accessibility.